Therapeutic Potential of Naltrexone in the Niche of Psychopharmacology
Therapeutic Potential of Naltrexone in the Niche of Psychopharmacology

Therapeutic Potential of Naltrexone in the Niche of Psychopharmacology

Psychopharmacol Bull. 2024 Jul 8;54(3):97-99.

ABSTRACT

NTX is FDA-approved for opiate and alcohol use disorders as anti-craving agent. It has been used successfully off-label in other psychiatric indications. Here, we shed some light on these while examining the extant evidence.

PMID:38993658 | PMC:PMC11235578